NCT02167841

Brief Summary

Background: The incidence of breech presentation in pregnant women is 4%. The situation can be treated by two methods. The first is a version of the fetus from breech presentation to head presentation, which can be performed in several ways, such as, an action called EXTERNAL CEPHALIC VERSION as well as the Knee-Chest position by the pregnant mother and the second is a cesarean section. In this study we wish to investigate if the Knee-Chest position is as effective as the ECV action and as a result to decrease the need for ECV. Hypotheses: According to our assumption, the Knee-Chest position can reduce the need for the ECV action. Objectives: Investigate whether daily Knee-Chest position is as effective as ECV. Methods: The investigators will conduct a "randomized clinical trial" study. Every pregnant woman in a breech presentation with a singleton between weeks 28-32 will be randomly assigned into one of two groups. In the first group the women will perform daily the Knee-Chest position between weeks 32-37. In week 37 the investigators will check via ultra sound if there was a successful version (if not, the woman would go to ECV) in the second group we will perform ECV without doing maternal Knee-Chest position before. Every woman will fill a questionnaire which includes gynecological history and details regarding the degree of persistence and performance of the activity. At the end of this process the investigators will analyze the results and will come to the conclusions. Significance: With ECV there are number of risks and complications such as fetal distress, placental abruption, rupture of membrane, amniotic fluid embolism or damage to the uterus. The frequency of these complications is 1%-2%. If it is discovered that the Knee-Chest position is effective as the ECV action, the investigators will recommend every patient to persist with this position and avoid the ECV action and the risks it entails.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

June 11, 2014

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 19, 2014

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
Last Updated

June 20, 2014

Status Verified

June 1, 2014

Enrollment Period

1.8 years

First QC Date

June 11, 2014

Last Update Submit

June 19, 2014

Conditions

Keywords

Breech presentation,External cephalic version,Maternal posture,Pregnancy,Caesarean section.

Outcome Measures

Primary Outcomes (1)

  • number of participants

    up to 5 weeks

Study Arms (2)

Knee-Chest position

EXPERIMENTAL

In this arm, the women will perform daily the Knee-Chest position between weeks 32-37. In week 37 the investigators will check via ultra sound if there was a successful version (if not, the woman would go to External Cephalic Version)

Behavioral: Knee-Chest Position

External Cephalic Version

NO INTERVENTION

In this group the women will perform External Cephalic Version without doing maternal Knee-Chest position before.

Interventions

Knee-Chest position

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant woman in a breech presentation with a singleton between weeks 28-32.

You may not qualify if:

  • Antepartum Hemorrhage.
  • Premature rupture of membranes.
  • Placenta Previa.
  • Oligohydramnios.
  • Twin Pregnancy.
  • Uterine malformation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Meir Hospital

Kfar Saba, Israel

Location

MeSH Terms

Conditions

Breech Presentation

Interventions

Knee-Chest Position

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

PostureMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2014

First Posted

June 19, 2014

Study Start

June 1, 2014

Primary Completion

April 1, 2016

Study Completion

April 1, 2016

Last Updated

June 20, 2014

Record last verified: 2014-06

Locations